TY - JOUR
T1 - Strand and cell type-specific function of microRNA-126 in angiogenesis
AU - Zhou, Qinbo
AU - Anderson, Chastain
AU - Hanus, Jakub
AU - Zhao, Fangkun
AU - Ma, Jing
AU - Yoshimura, Akihiko
AU - Wang, Shusheng
N1 - Funding Information:
S.W. was supported by a Startup fund from Tulane University, NIH Grant EY021862, a career development award from the Research to Prevent Blindness foundation, and a BrightFocus Foundation Award in Age-related Macular Degeneration. Q.Z. was supported by an American Heart Association Southeast Affiliate Postdoctoral fellowship.
Publisher Copyright:
© The American Society of Gene & Cell Therapy.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - microRNAs or miRs have been shown to be pivotal modulators of vascular development. The strand and cell type-specific function of miR-126 in angiogenesis, especially pathological angiogenesis, remains poorly defined. We characterized the retinal vascular phenotype of miR-126-/- mice, and tested the function of miR-126 strands (miR-126-3p and -5p) using in vitro angiogenesis models and a mouse model of neovascular age-related macular degeneration. We found that miR-126 is critical for retinal vascular development but has dual function in pathological angiogenesis. miR-126-/- mice showed defective postnatal retinal vascular development and remodeling, which is partially rescued by genetic knockout of its target gene Spred-1. Surprisingly, either silencing miR-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced choroidal neovascularization. To dissect the underlying mechanism, we found in endothelial cells, silencing of miR-126-3p repressed angiogenesis, while overexpression of miR-126-5p enhanced angiogenesis. However, in retinal pigment epithelial cells, miR-126-3p repressed vascular endothelial growth factor (VEGF-A) expression via a novel mechanism of regulating αB-Crystallin promoter activity and by directly targeting VEGF-A 3′-untranslated region. These findings provide first genetic evidence that miR-126 is required for the development of different retinal vascular layers, and also uncover a strand and cell type-specific function of miR-126 in ocular pathological angiogenesis.
AB - microRNAs or miRs have been shown to be pivotal modulators of vascular development. The strand and cell type-specific function of miR-126 in angiogenesis, especially pathological angiogenesis, remains poorly defined. We characterized the retinal vascular phenotype of miR-126-/- mice, and tested the function of miR-126 strands (miR-126-3p and -5p) using in vitro angiogenesis models and a mouse model of neovascular age-related macular degeneration. We found that miR-126 is critical for retinal vascular development but has dual function in pathological angiogenesis. miR-126-/- mice showed defective postnatal retinal vascular development and remodeling, which is partially rescued by genetic knockout of its target gene Spred-1. Surprisingly, either silencing miR-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced choroidal neovascularization. To dissect the underlying mechanism, we found in endothelial cells, silencing of miR-126-3p repressed angiogenesis, while overexpression of miR-126-5p enhanced angiogenesis. However, in retinal pigment epithelial cells, miR-126-3p repressed vascular endothelial growth factor (VEGF-A) expression via a novel mechanism of regulating αB-Crystallin promoter activity and by directly targeting VEGF-A 3′-untranslated region. These findings provide first genetic evidence that miR-126 is required for the development of different retinal vascular layers, and also uncover a strand and cell type-specific function of miR-126 in ocular pathological angiogenesis.
UR - http://www.scopus.com/inward/record.url?scp=84975311583&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975311583&partnerID=8YFLogxK
U2 - 10.1038/mt.2016.108
DO - 10.1038/mt.2016.108
M3 - Article
C2 - 27203443
AN - SCOPUS:84975311583
SN - 1525-0016
VL - 24
SP - 1823
EP - 1835
JO - Molecular Therapy
JF - Molecular Therapy
IS - 10
ER -